Cargando…
Monitoring in practice – How are UK academic clinical trials monitored? A survey
BACKGROUND: Despite the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) encouraging the use of risk-based monitoring for trials in 2013, there remains a lack of evidence-based guidelines on how to monitor. We surveyed the academic United Kingdom Clinical Research Collaborat...
Autores principales: | Love, Sharon B., Yorke-Edwards, Victoria, Lensen, Sarah, Sydes, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953230/ https://www.ncbi.nlm.nih.gov/pubmed/31918743 http://dx.doi.org/10.1186/s13063-019-3976-1 |
Ejemplares similares
-
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
por: Lensen, Sarah, et al.
Publicado: (2020) -
Making a distinction between data cleaning and central monitoring in clinical trials
por: Love, Sharon B, et al.
Publicado: (2021) -
Lack of transparent reporting of trial monitoring approaches in
randomised controlled trials: A systematic review of contemporary protocol
papers
por: Hsieh, Shao-Fan, et al.
Publicado: (2023) -
What is the purpose of clinical trial monitoring?
por: Love, Sharon B., et al.
Publicado: (2022) -
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data
por: Love, Sharon B., et al.
Publicado: (2021)